Has Benjamin Platt, MD received payments from drug or device companies?

Yes. Drug and device makers reported $18,111 in general payments to Benjamin Platt, MD across 111 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Benjamin Platt, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Benjamin Platt, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Benjamin Platt, MD

Pain Medicine · Vancouver, WANPI 1952466567

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $13,370 of the $18,111 with a category attached, or 73.8%. Medtronic accounts for 76.1% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $8,372 and has fallen 66.2% since, to $2,826 in 2024. Among pain medicine clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,111in general payments, 2019–2025

Across 111 payments — averaging $163.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$14K
Nevro Corp.$4K
Saluda Medical Americas, Inc.$178
Abbott$148
MML US, Inc.$103
Vertos Medical, Inc.$26
plus $44 from 2 others

$7,455in research payments, 2019–2025

Across 4 payments — averaging $1863.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$7K

What the payments were for

Speaking & faculty fees$13,37074%
Travel & lodging$2,79515%
Food & beverage$1,94611%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	68	$13,783
Nevro Corp.	33	$3,828
Saluda Medical Americas, Inc.	1	$178
Abbott	4	$148
MML US, Inc.	2	$103
Vertos Medical, Inc.	1	$26
Zest Holdings, LLC	1	$24
Boston Scientific	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,111 in reported general payments places this provider in the 90th percentile of 124 pain medicine providers in Washington.

See all pain medicine providers in Washington →

Medicare billing

Part B allowed, 2024

$107,020

Medicare patients

262

Services billed

1,258

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OxycontinOxycodone Hcl	111	$98,999
BelbucaBuprenorphine Hcl	42	$31,465
Oxycodone Hcl	1,192	$28,701
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	683	$24,750
Morphine Sulfate ErMorphine Sulfate	486	$21,555
Xtampza ErOxycodone Myristate	28	$19,686
Fentanyl	200	$19,351
Buprenorphine	88	$18,949
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl	92	$16,025
LyricaPregabalin	12	$14,488
MovantikNaloxegol Oxalate	22	$12,224
Hydromorphone Hcl	392	$10,917
NucyntaTapentadol Hcl	17	$10,433
Hydromorphone ErHydromorphone Hcl	26	$8,044
Hysingla ErHydrocodone Bitartrate	11	$6,923

Paid to pharmacies, not to this prescriber.

Other pain medicine in Vancouver

Sloane YuVancouver$42K
Peter MullinsVancouver$4K
Guannan GeVancouver$2K
Jennifer LeeKirkland$318K
Steven StanosSeattle$206K
Corrie AndersonSeattle$102K
Gregory TermanSeattle$95K
Caroline HarstroemEverett$74K
Praveen MambalamEdmonds$32K
Miroslav BackonjaSeattle$22K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →